These mean that in order to defeat the refractory and drug-resistant pancreatic cancer with MUC4 expression, some pathways can be explored besides repressing MUC4 transcription [45, 46], as follows: 1) To improve reversed effects of domain-lacking. The gene discussed is MUC4; the disease is familial pancreatic carcinoma.